J Clavier

1.2k total citations
33 papers, 472 citations indexed

About

J Clavier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J Clavier has authored 33 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J Clavier's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). J Clavier is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). J Clavier collaborates with scholars based in France, United States and Switzerland. J Clavier's co-authors include Christophe Leroyer, Emmanuel Oger, Dominique Mottier, Luc Bressollette, Emmanuelle Le Moigne, Michel Nonent, Claude Chastang, B Lebeau, A Depierre and Élisabeth Quoix and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, American Journal of Obstetrics and Gynecology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J Clavier

29 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Clavier France 10 243 194 159 97 66 33 472
J.L. Balibrea Spain 12 106 0.4× 150 0.8× 201 1.3× 143 1.5× 138 2.1× 18 562
Ángel Olazábal Spain 8 895 3.7× 445 2.3× 89 0.6× 61 0.6× 178 2.7× 11 1.1k
Wanda M. Hinshaw United States 6 150 0.6× 40 0.2× 120 0.8× 77 0.8× 102 1.5× 9 335
Daniele Fagnani Italy 9 164 0.7× 109 0.6× 190 1.2× 45 0.5× 53 0.8× 24 376
Marie‐Anne Collignon France 7 183 0.8× 53 0.3× 228 1.4× 178 1.8× 78 1.2× 11 436
G.-F. von Tempelhoff Germany 9 53 0.2× 54 0.3× 153 1.0× 99 1.0× 53 0.8× 24 366
J Brush United Kingdom 8 137 0.6× 97 0.5× 114 0.7× 55 0.6× 138 2.1× 13 363
Jason Wachsmann United States 9 209 0.9× 124 0.6× 100 0.6× 31 0.3× 71 1.1× 19 524
Jean Chidiac France 11 59 0.2× 72 0.4× 172 1.1× 152 1.6× 62 0.9× 23 371
Michiels Jj Netherlands 8 57 0.2× 45 0.2× 300 1.9× 206 2.1× 125 1.9× 22 535

Countries citing papers authored by J Clavier

Since Specialization
Citations

This map shows the geographic impact of J Clavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Clavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Clavier more than expected).

Fields of papers citing papers by J Clavier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Clavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Clavier. The network helps show where J Clavier may publish in the future.

Co-authorship network of co-authors of J Clavier

This figure shows the co-authorship network connecting the top 25 collaborators of J Clavier. A scholar is included among the top collaborators of J Clavier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Clavier. J Clavier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Oger, Emmanuel, Christophe Leroyer, Luc Bressollette, et al.. (1998). Evaluation of a New, Rapid, and Quantitative D-Dimer Test in Patients with Suspected Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 158(1). 65–70. 85 indexed citations
4.
Leroyer, Christophe, et al.. (1998). Dirithromycin Concentrations in Bronchial Mucosa and Secretions. Respiration. 65(5). 381–385. 1 indexed citations
5.
Escoffre‐Barbe, Martine, Emmanuel Oger, Christophe Leroyer, et al.. (1998). Evaluation of a New Rapid D-Dimer Assay for Clinically Suspected Deep Venous Thrombosis (Liatest D-Dimer). American Journal of Clinical Pathology. 109(6). 748–753. 40 indexed citations
6.
Leroyer, Christophe, Luc Bressollette, Emmanuel Oger, et al.. (1998). Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis. Pathophysiology of Haemostasis and Thrombosis. 28(2). 70–77. 24 indexed citations
7.
Thomas, P., J P Kleisbauer, G. Robinet, et al.. (1997). Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy.. Lung Cancer. 18(1). 71–81. 2 indexed citations
8.
Oger, Emmanuel, Christophe Leroyer, Emmanuelle Le Moigne, et al.. (1997). The Value of a Risk Factor Analysis in Clinically Suspected Deep Venous Thrombosis. Respiration. 64(5). 326–330. 24 indexed citations
9.
Depierre, A, Claude Chastang, Élisabeth Quoix, et al.. (1994). Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial. Annals of Oncology. 5(1). 37–42. 184 indexed citations
10.
Robinet, G., et al.. (1994). [Small cell bronchial cancer in a 17-year-old young man].. PubMed. 11(6). 607–9. 1 indexed citations
11.
Leroyer, Christophe, et al.. (1993). Mesenchymal Cystic Hamartoma of the Lung. Respiration. 60(5). 305–306. 9 indexed citations
12.
Robinet, G., S. Gouva, J Clavier, et al.. (1991). [Chemotherapy with cisplatin and 5-fluorouracil in inoperable brain metastases of bronchopulmonary cancers].. PubMed. 78(9). 831–7. 1 indexed citations
13.
Dewitte, Jean‐Dominique, et al.. (1986). Predictive value of T-cell subset derangements in lung cancer. Medical Oncology and Tumor Pharmacotherapy. 3(2). 83–85. 1 indexed citations
14.
Mabin, Dominique, et al.. (1986). Neuropathies peripheriques au cours des traitements au cisplatine: etude clinique et electrophysiologique de 11 cas. Revue d Electroencé phalographie et de Neurophysiologie Clinique. 15(4). 341–348. 1 indexed citations
15.
Clavier, J, et al.. (1986). [Lack of T lymphocytes expressing CD4 antigen during pollenosis].. PubMed. 18(10). 7–11. 1 indexed citations
16.
Mabin, Dominique, et al.. (1985). Interet des potentiels evoques visuels et somesthesiques et de l'electroencephalogramme chez les insuffisants respiratoires chroniques. Revue d Electroencé phalographie et de Neurophysiologie Clinique. 15(1). 53–57. 2 indexed citations
17.
Youinou, Pierre, et al.. (1984). Antiperinuclear activity in lung carcinoma patients. Cancer Immunology Immunotherapy. 18(2). 80–1. 6 indexed citations
18.
Miossec, Pierre, et al.. (1984). Lowered Fc IgG Receptor-Bearing T Lymphocytes Correlate with Non-Organ-Specific Autoantibodies in Silicosis. International Archives of Allergy and Immunology. 73(3). 212–215. 6 indexed citations
19.
Clavier, J, et al.. (1984). Surgery and chemotherapy. Journal of Thoracic and Cardiovascular Surgery. 88(5). 754–757. 15 indexed citations
20.
Brière, Josette, et al.. (1983). [Solitary fibrous tumors of the visceral pleura. 5 cases].. PubMed. 12(9). 561–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026